Dr. Usama Gergis, MD
Claim this profileThomas Jefferson University
Studies Cancer
Studies Hematologic Malignancies
13 reported clinical trials
29 drugs studied
Area of expertise
1Cancer
HLA-A negative
HLA-A positive
HLA positive
2Hematologic Malignancies
HLA positive
HLA negative
Affiliated Hospitals
Clinical Trials Usama Gergis, MD is currently running
Reduced-Intensity Conditioning
for Blood Cancers
This phase II clinical trial evaluates whether a modified modality of conditioning reduces treatment-related mortality (TRM) in patients who undergo a hematopoietic stem cell transplant (HSCT) for a hematological malignancy. HSCT is a curative therapy for many hematopoietic malignancies, however this regimen results in higher rates of TRM than other forms of treatment. In recent years, less intense conditioning regimens with radiation and chemotherapy prior to HSCT have been developed. Radiation therapy uses high energy sources to kill cancer cells and shrink tumors while chemotherapy drugs like fludarabine and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This study evaluates whether a two-step approach with lower-intensity regimens of these treatments prior to HSCT reduces the rate of TRM.
Recruiting1 award Phase 28 criteria
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
More about Usama Gergis, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Usama Gergis, MD has experience with
- Cyclophosphamide
- Mycophenolate Mofetil
- Tacrolimus
- Total-Body Irradiation
- Chemotherapy Agents
- Fludarabine
Breakdown of trials Usama Gergis, MD has run
Cancer
Hematologic Malignancies
Non-Hodgkin's Lymphoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Usama Gergis, MD specialize in?
Usama Gergis, MD focuses on Cancer and Hematologic Malignancies. In particular, much of their work with Cancer has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Usama Gergis, MD currently recruiting for clinical trials?
Yes, Usama Gergis, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Usama Gergis, MD has studied deeply?
Yes, Usama Gergis, MD has studied treatments such as Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus.
What is the best way to schedule an appointment with Usama Gergis, MD?
Apply for one of the trials that Usama Gergis, MD is conducting.
What is the office address of Usama Gergis, MD?
The office of Usama Gergis, MD is located at: Thomas Jefferson University, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.